Each year since 2009, the National Institutes of Health (NIH) Clinical Center and National Center for Advancing Translational Sciences (NCATS) has hosted Rare Disease Day at NIH to participate in the global observance. This year, we attended the event and heard several inspiring presentations from a range of rare disease stakeholders.
patient recruitment for clinical trials
On February 28, rare-disease communities around the world come together to advocate for an increase in research focused on rare diseases. When it comes to clinical research for rare and orphan diseases, the relationship with the patient and advocacy groups is critical to success.
Competing studies can be a challenge when enrolling patients in clinical trials. But when those studies are conducted by one sponsor, the need to engage with a single patient population can quickly turn into an asset and huge savings.
In the United States alone, more than 5 million people over age 65 have been diagnosed with Alzheimer’s disease. Today there is still no cure, but there is hope. More than 79 compounds are in clinical development for Alzheimer’s and other cognitive related diseases.
Faced with the challenge of motivating the at-risk population to get free memory testing, one clinical trial site had the novel idea of hosting a free movie and memory screening event.
If patient recruitment difficulties account for up to 80% of study delays, why not take advantage of the time before the site initiation visit (SIV) to prepare the site for patient enrollment? At CHI’s Summit for Clinical Ops Executives (SCOPE) January 24th-26th in Miami, UBC will share a new approach to optimizing study start-up by utilizing ten proven pre-enrollment tactics.
We’ve entered an age where more people own a mobile device than a toothbrush. As strange and remarkable as that may seem, it presents an unprecedented opportunity for the pharmaceutical industry. Sponsors are quickly learning how to leverage this new level of real-time connectivity to engage patients and improve workflows.
Our final installment in the Summer Roadblock Blog series shows sponsors how social media and text messaging programs can help a traditional patient recruitment campaign turn the corner.
More and more, sponsors recognize the importance of the patient perspective in clinical research. And when it comes to clinical research for rare and orphan diseases, the relationship with patient and advocacy groups is especially important
When the August heat has you running for the pool, and it seems like the whole world is on vacation, it can be hard to think ahead to fall. However, when it comes to patient recruitment for clinical research, this is a very important time.
I moved to Boston recently, and I’m still figuring out the lay of the land. Even when I’m sure of my destination, my app usually re-routes me and I sometimes find a shorter way to get there.
The same can be said for clinical trial recruitment strategies. In the summer months, we find that a lot of our clients are re-assessing. How is the study tracking to its milestones? What goals have been communicated to senior management?